# Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole Genome

> **NCT02904967** · NA · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 221 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **BIOLOGICAL:** Extra Blood Draw

## Key facts

- **NCT ID:** NCT02904967
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-18
- **Primary completion:** 2016-07-18
- **Final completion:** 2023-08-09
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02904967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02904967, "Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole Genome". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02904967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*